BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

39 related articles for article (PubMed ID: 23006489)

  • 1. Cost-effectiveness of a cardiac contractility modulation device in heart failure with normal QRS duration.
    Witte K; Hasenfuss G; Kloppe A; Burkhoff D; Green M; Moss J; Peel A; Mealing S; Durand Zaleski I; Cowie MR
    ESC Heart Fail; 2019 Dec; 6(6):1178-1187. PubMed ID: 31997539
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Cost-effectiveness analysis of leadless cardiac resynchronization therapy.
    Wijesuriya N; Mehta V; Vere F; Howell S; Behar JM; Shute A; Lee M; Bosco P; Niederer SA; Rinaldi CA
    J Cardiovasc Electrophysiol; 2023 Dec; 34(12):2590-2598. PubMed ID: 37814470
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Cost-utility of cardiac contractility modulation in patients with heart failure with reduced ejection fraction in Italy.
    Narducci ML; Nurchis MC; Ballacci F; Giordano F; Calabrò GE; Massetti M; Crea F; Aspromonte N; Damiani G
    ESC Heart Fail; 2024 Feb; 11(1):229-239. PubMed ID: 37943287
    [TBL] [Abstract][Full Text] [Related]  

  • 4. An economic evaluation of a self-care intervention in persons with heart failure and diabetes.
    Reilly CM; Butler J; Culler SD; Gary RA; Higgins M; Schindler P; Butts B; Dunbar SB
    J Card Fail; 2015 Sep; 21(9):730-7. PubMed ID: 26164214
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The Use of Pediatric Ventricular Assist Devices in Children's Hospitals From 2000 to 2010: Morbidity, Mortality, and Hospital Charges.
    Mansfield RT; Lin KY; Zaoutis T; Mott AR; Mohamad Z; Luan X; Kaufman BD; Ravishankar C; Gaynor JW; Shaddy RE; Rossano JW
    Pediatr Crit Care Med; 2015 Jul; 16(6):522-8. PubMed ID: 25850863
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Can telemonitoring reduce hospitalization and cost of care? A health plan's experience in managing patients with heart failure.
    Maeng DD; Starr AE; Tomcavage JF; Sciandra J; Salek D; Griffith D
    Popul Health Manag; 2014 Dec; 17(6):340-4. PubMed ID: 24865986
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Cost-effectiveness of a nurse facilitated, cognitive behavioural self-management programme compared with usual care using a CBT manual alone for patients with heart failure: secondary analysis of data from the SEMAPHFOR trial.
    Mejía A; Richardson G; Pattenden J; Cockayne S; Lewin R
    Int J Nurs Stud; 2014 Sep; 51(9):1214-20. PubMed ID: 24559909
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Medical resource use, costs, and quality of life in patients with acute decompensated heart failure: findings from ASCEND-HF.
    Reed SD; Kaul P; Li Y; Eapen ZJ; Davidson-Ray L; Schulman KA; Massie BM; Armstrong PW; Starling RC; O'Connor CM; Hernandez AF; Califf RM
    J Card Fail; 2013 Sep; 19(9):611-20. PubMed ID: 24054337
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Effectiveness of a multidimensional home nurse led heart failure disease management program--a French nationwide time-series comparison.
    Agrinier N; Altieri C; Alla F; Jay N; Dobre D; Thilly N; Zannad F
    Int J Cardiol; 2013 Oct; 168(4):3652-8. PubMed ID: 23809709
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Cost-utility analysis of the EVOLVO study on remote monitoring for heart failure patients with implantable defibrillators: randomized controlled trial.
    Zanaboni P; Landolina M; Marzegalli M; Lunati M; Perego GB; Guenzati G; Curnis A; Valsecchi S; Borghetti F; Borghi G; Masella C
    J Med Internet Res; 2013 May; 15(5):e106. PubMed ID: 23722666
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Cost-effectiveness of a Multicomponent Intervention for Hypertension Control in Low-Income Settings in Argentina.
    Zhang Y; Yin L; Mills K; Chen J; He J; Palacios A; Riviere AP; Irazola V; Augustovski F; Shi L
    JAMA Netw Open; 2021 Sep; 4(9):e2122559. PubMed ID: 34519769
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Health State Utilities of Patients with Heart Failure: A Systematic Literature Review.
    Di Tanna GL; Urbich M; Wirtz HS; Potrata B; Heisen M; Bennison C; Brazier J; Globe G
    Pharmacoeconomics; 2021 Feb; 39(2):211-229. PubMed ID: 33251572
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Cardiac resynchronization therapy in patients with mild heart failure is a reversal therapy.
    Ali-Hassan-Al-Saegh S; Mirhosseini SJ; Karimi-Bondarabadi AA; Sahidzadeh A; Mahdavi P; Tahernejad M; Heydari S; Weymann A; Zeriouh M; Sabashnikov A; Popov AF
    Indian Heart J; 2017; 69(1):112-118. PubMed ID: 28228294
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Cost-effectiveness of cardiac resynchronization therapy: perspective from Argentina.
    Poggio R; Augustovsky F; Caporale J; Irazola V; Miriuka S
    Int J Technol Assess Health Care; 2012 Oct; 28(4):429-35. PubMed ID: 23006489
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Cost-effectiveness of cardiac resynchronization therapy in patients with asymptomatic to mild heart failure: insights from the European cohort of the REVERSE (Resynchronization Reverses remodeling in Systolic Left Ventricular Dysfunction).
    Linde C; Mealing S; Hawkins N; Eaton J; Brown B; Daubert JC;
    Eur Heart J; 2011 Jul; 32(13):1631-9. PubMed ID: 21112898
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The long-term cost-effectiveness of cardiac resynchronization therapy with or without an implantable cardioverter-defibrillator.
    Yao G; Freemantle N; Calvert MJ; Bryan S; Daubert JC; Cleland JG
    Eur Heart J; 2007 Jan; 28(1):42-51. PubMed ID: 17110403
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Cost-effectiveness analysis of cardiac resynchronization therapy in patients with NYHA I and NYHA II heart failure in Spain.
    Almenar L; Díaz B; Quesada A; Crespo C; Martí B; Mealing S; Linde C; Daubert C
    Int J Technol Assess Health Care; 2013 Apr; 29(2):140-6. PubMed ID: 23552131
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The clinical effectiveness and cost-effectiveness of cardiac resynchronisation (biventricular pacing) for heart failure: systematic review and economic model.
    Fox M; Mealing S; Anderson R; Dean J; Stein K; Price A; Taylor RS
    Health Technol Assess; 2007 Nov; 11(47):iii-iv, ix-248. PubMed ID: 17999842
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Economic impact of cardiac resynchronization therapy in patients with heart failure. Available evidence and evaluation of the CRT-Eucomed model for analysis of cost-effectiveness].
    Fattore G; Landolina M; Bontempi L; Cacciatore G; Curnis A; Gulizia M; Padeletti L; Mazzei L; Tavazzi L;
    Ital Heart J Suppl; 2005 Dec; 6(12):796-803. PubMed ID: 16444923
    [TBL] [Abstract][Full Text] [Related]  

  • 20.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 2.